Imipenem has excellent antimicrobial activity owing in part to ,-lactamase stability. We found that only 2 of over 350 Bacteroides fragilis group clinical isolates were resistant to imipenem, with an MIC of more than 16 ,ug/ml. These two isolates from the Tufts Anaerobe Laboratory (TAL) were resistant to all other P-lactam agents tested. The organisms were able to inactivate imipenem in broth cultures and contained similar P-lactamases that were able to hydrolyze carbapenems, cephamycins, cephalosporins, and penicillins. The molecular sizes of the ,-lactamases in TAL2480 and TAL3636 were estimated to be 44,000 daltons. The novel I8-lactamase contained Zn2' as a cofactor. An additional factor contributing to resistance was determined. The outer membranes of these two organisms were found to limit free diffusion of the drugs into the periplasm. This novel ,I-lactamase, associated with a barrier to drug permeation, resulted in high-grade ,-lactam drug resistance.
Bacteroides fragilis is the most important anaerobic bacterial pathogen of humans. Clinical isolates generally contain ,-lactamase and as a result are frequently resistant to the cephalosporins, including the broad-spectrum cephalosporins, as well as penicillins (2, 19) . Only cephamycins, such as cefoxitin, and carbapenems, such as imipenem, are resistant to hydrolysis by the frequently described B. fragilis PIlactamase (2, 5, 14) . Resistance to imipenem is rare in B. fragilis. We found that only 2 of over 350 isolates tested were resistant to imipenem. We investigated the P-lactamase activity in these two strains.
MATERIALS AND METHODS Antimicrobial drugs. Standard powders were obtained from various manufacturers (19) .
Isolates. Bacterial identification was performed by the established method (9) . Tufts Anaerobe Laboratory (TAL) isolate 2480 was isolated from the blood of a patient at the New England Deaconess Hospital, Boston, Mass. The patient died of uncontrolled sepsis while receiving cefoxitin and clindamycin. TAL3636 was isolated from a patient at the New England Medical Center Hospitals, Boston, Mass. This diabetic patient failed to respond to cefoxitin therapy and required an amputation for a foot infection.
Media and incubation. The isolates were transported, stored, and incubated as previously described (10, 19) . Brain heart infusion broth (Scott Laboratories, Inc., Fiskeville, R.I.) supplemented with 0.0005% hemin and 0.5% yeast extract (BHIS) was used for the liquid growth medium. BHIS was solidified, with 1.5% agar. Blood agar plates consisted of BHIS plates with 5% defibrinated sheep blood.
Susceptibility testing. The MICs were determined by an agar dilution method using a Steers replicator and anaerobic chamber techniques previously described (4, 19, 20) . The MICs and MBCs were also determined by microtiter methods (20 for agar dilution testing. Induction of resistance was assayed by growing the organisms in broth medium with and without imipenem (5 jig/ml), cefoxitin (5 ,ug/ml), or ampicillin (20 ,ug/ml). The organisms were exposed to the drugs in both overnight and 4-h incubations.
j8-Lactamase induction. ,-Lactamase induction was tested by incubating isolates in BHIS with and without cefoxitin (5 ,ug/ml) or ampicillin (20 ,ug/ml). Serial samples were obtained hourly for 8 h after the addition of the drug. Whole and toluene-treated cells were assayed for P-lactamase-specific activity by using nitrocefin as described below.
Drug assay. The cefoxitin concentration in BHIS was measured by both high-pressure liquid chromatography and bioassays (5) . The concentrations of SCH34343, imipenem, and aztreonam in broth cultures were determined by a bioassay identical to the method used for cefoxitin.
I8-Lactamase assay. The P-lactamase activity of the crude enzyme extracts and purified fractions was determined by a spectrophotometric technique (11, 13) . Drug destruction was monitored at the following wavelengths: cefoxitin, 261 nm; nitrocefin, 482 nm; cephaloridine, 255 nm; moxalactam, 270 nm; imipenem, 297 nm; cefotaxime, 267 nm; cephalothin, 265 nm (3, 11, 13, 16, 22) . Penicillin hydrolysis was assayed by spectrophotometry at 236 nm (11) . The reactions were monitored in a dual-beam spectrophotometer (Coleman 124; The Perkin-Elmer Corp., Maywood, Ill.) maintained at a temperature of 30°C. One unit of ,-lactamase activity was defined as that amount of enzyme that can destroy 1 ,umol of drug per min in the initial linear phase of the reaction. ,-Lactamase-specific activity of a sample was calculated by dividing the ,-lactamase activity by the amount of protein (units per milligram) in the reaction mixture. MichaelisMenten constants were calculated from initial reaction velocities by the method of least-squares using at least eight concentrations of substrate (Lineweaver-Burk plots). Concentrations (1 mM) of aztreonam, iodine, p-chloromercuribenzoate, and clavulanic acid and sulbactam and various concentrations of EDTA and 1,10-phenanthroline were incubated with the purified enzyme for 5 min at 22°C and tested as inhibitors of the ,-lactamase reaction with nitrocefin (100 ,uM) as the substrate. Table 1 . This resistance included cephalosporins, including broad-spectrum cephalosporins, carbapenems, penicillins, and monobactams. No induction to higher levels of resistance was found when the two isolates were preincubated in the presence of cefoxitin, ampicillin, or imipenem. Increasing the inoculum from 106 to 108 resulted in twofold higher MICs and MBCs when tested with imipenem, ampicillin, and cefoxitin (data not shown).
Broth inactivation. Both TAL2480 and TAL3636 were able to rapidly inactivate imipenem and cefoxitin in broth culture. Less than 1% of the initial 50 ,ug of imipenem per ml remained 8 h after incubation with either TAL2480 or TAL3636. At 8 h, 66% of the drug remained in the control tube. The controls consisted of the drug in broth with a susceptible B. fragilis isolate or drug in broth alone. Likewise, at 24 h, less than 1% of the initial 100 ,ug of cefoxitin per ml remained after incubation with TAL2480 or TAL3636 compared with 81% in the controls. SCH34343 was also destroyed but aztreonam was not destroyed in broth cultures under the same conditions. ,3-Lactamase content. No induction to higher levels of cellular P-lactamase content was detected when broth cultures of TAL2480 or TAL3636 were exposed to either 20 ,ug of ampicillin or 5 ,ug of cefoxitin per ml during an 8-h period.
13-Lactamase physical characteristics. The ,B-lactamases of TAL2480 and TAL3636 had the same estimated molecular size of 44,000 daltons. The 1-lactamases failed to focus well enough to establish a reliable pl, in contrast to control samples containing TEM-1 or the P-lactamase from other B.
fragilis isolates. The optimal pH of f3-lactamase activity of the purified TAL2480 enzyme was 7.0. The enzyme maintained 50% of maximal activity between pH 6.0 and 7.7. The optimum temperature for the 3-lactamase reaction was 36°C.
Freezing of the enzyme samples resulted in >99% loss of activity.
3-Lactamase purification and substrate profile. The 13- lactamase of TAL2480 was partially purified ( Table 2 ). The purest sample had four contaminating bands seen by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The fractions were assayed for both cefoxitin-and nitrocefindegrading activity throughout the purification procedure. Both activities copurified. The kinetic parameters of the partially purified TAL2480 enzyme were determined ( Table  3 ). The enzyme hydrolyzes most ,B-lactams. The substrates that are usually considered more stable to B. fragilis Plactamases, cefoxitin and moxalactam, had higher Kms and modestly lower relative Vmaxs compared with the older cephalosporins. Imipenem was hydrolyzed more rapidly than moxalactam or cefoxitin were. These results suggest a broad substrate profile for this enzyme.
There was no significant difference in the substrate profiles between the purified and crude enzymes of TAL2480. The substrate profiles of the clarified crude lysates of TAL2480 and TAL3636 were the same.
Inhibitors. The partially purified P-lactamase of TAL2480
was not inhibited by 1 mM clavulanic acid or sulbactam. It was inhibited by 1 mM iodide, dithiothreitol, p-chloromercuribenzoate, EDTA, and 1,10-phenanthroline (less than 1% activity remained). After a 10-fold dilution of the EDTAtreated enzyme, inhibition was not reversed by Mn2+, Mg2+, Ca2+, Fe2+, or Ni2+; however, 1 mM Zn2+ or Co2+ completely reversed the inhibition. Aztreonam at a concentration of 1 mM did not inhibit nitrocefin hydrolysis.
,I-Lactamase crypticity. The crypticity values for imipenem, cefoxitin, and nitrocefin varied from 14 to 40 (Table 4) .
DISCUSSION
The resistance of B. fragilis to penicillins and cephalosporins is mediated primarily by the chromosomal ,-lactamases present in most isolates (14, 15, 23) . The activity of cefoxitin and imipenem against these organisms is largely due to resistance of the drug to the frequently described 1B-lactamases (2). Our data indicated that B. fragilis acquired a new class of ,B-lactamase that inactivates a wide range of 1-lactam substrates usually considered stable to hydrolysis, including cephamycins and carbapenems. The 1-lactamase (6) . The 1-lactamases of TAL2480 and TAL3636 are similar to the frequently described B. fragilis ,B-lactamases in that they also are cell bound and expressed constitutively (15) . Other laboratories have recently reported novel ,3-lactamase activity in B. fragilis. Sato et al. reported an enzyme which primarily acts as a penicillinase (18) . Yotsuji et al. reported a broad-spectrum 1-lactamase that has a substrate profile similar to those of the TAL2480 and TAL3636 enzymes (23) . However, their isolate is probably different in that it is susceptible to piperacillin and imipenem. EDTA inhibition was not mentioned in their report.
Outer membrane permeability to antibiotics can be an integral component of 3-lactam drug resistance in gramnegative bacteria. 13-Lactam drug hydrolysis in the periplasmic space coupled with limited permeability and, thus, limited drug influx can interact synergistically to maintain low levels of drug near the penicillin-binding proteins (12, 21, 24) . Crypticity values are inversely related to degree of permeability and are greater than 1 when the drug permeation is the rate-limiting step for 1-lactam hydrolysis. The values of 14 to 40 do suggest a degree of inhibition of drug penetration through the outer membrane for imipenem, cefoxitin, and nitrocefin in these isolates. Olsson et al. showed previously that limited outer membrane permeability in B. fragilis may contribute to ,B-lactam drug resistance (14) .
The discovery of this new resistance to a broad range of 13-lactam drugs in B. fragilis is clinically relevant. These isolates were fully pathogenic and were recovered from human infections. 3-Lactam drug resistance in B. fragilis is a dynamic process and may respond to selection pressure, as shown by outbreaks and clustering of cefoxitin resistance in various clinical centers (4) . Increased use of 13-lactamasestable compounds will result in new strategies by organisms to overcome the drug challenge. ,B-Lactam drug resistance in VOL. 30, 1986 B. fragilis will probably continue to be a problem in the foreseeable future.
